Corneal toxicity of propamidine

Arch Ophthalmol. 1988 Jan;106(1):68-9. doi: 10.1001/archopht.1988.01060130074031.

Abstract

Two patients with Acanthamoeba keratitis developed a corneal abnormality following prolonged treatment with topical 0.1% [corrected] propamidine isethionate. In both instances, withdrawal of drug therapy resulted in a gradual clearing of the keratopathy, with no permanent sequelae. The changes we observed may be confused with those of active Acanthamoeba infection.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acanthamoeba
  • Administration, Topical
  • Adult
  • Amebiasis / drug therapy
  • Amidines / adverse effects*
  • Animals
  • Benzamidines / administration & dosage
  • Benzamidines / adverse effects*
  • Benzamidines / therapeutic use
  • Corneal Diseases / chemically induced*
  • Corneal Diseases / pathology
  • Cysts / chemically induced
  • Female
  • Humans
  • Keratitis / etiology
  • Male

Substances

  • Amidines
  • Benzamidines
  • propamidine isethionate